Targeting eIF5A2 hypusination with bikinin sensitizes hepatocellular carcinoma to lenvatinib by suppressing TFEB-mediated autophagy
Human Cell · 18.07.2026 · 39 (8)
DOI: 10.1007/s13577-026-01426-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, online erschienen am 18.07.2026. Verfasst von Shuqian Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang, China. Hauptthemen laut MEDLINE: Phenylurea Compounds, Quinolines, Carcinoma, Hepatocellular, Autophagy. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) frequently develops resistance to lenvatinib, a multikinase inhibitor, necessitating the development of novel therapeutic strategies. Here, we identify bikinin as a potent eIF5A2 inhibitor through structure-based virtual screening (> 100,000 compounds) and demonstrate its synergistic effect with lenvatinib in HCC cells. Mechanistically, bikinin suppresses deoxyhypusine synthase (DHS)-mediated hypusination of eIF5A2, thereby downregulating the expression of transcription factor EB (TFEB). Furthermore, while DHS knockdown enhanced the sensitivity of HCC cells to lenvatinib, the addition of bikinin treatment provided no further significant sensitization. We also observed that the combination of bikinin and lenvatinib significantly promoted apoptosis and suppressed proliferation in HCC cells. Although TFEB overexpression conferred resistance to lenvatinib and activated autophagy, these effects were reversed by co-treatment with bikinin, which restored lenvatinib sensitivity and inhibited autophagic flux. Bikinin disrupts TFEB-driven autophagy, as evidenced by reduced LC3-II conversion, p62 accumulation, and decreased autophagosome formation. In in vivo experiments, the combination therapy with lenvatinib and bikinin achieved marked tumor regression, accompanied by suppressed Ki-67 expression and elevated TUNEL positivity. Finally, RNA-seq data identified TFEB downregulation as a critical mediator of this therapeutic sensitization. Our work unveils a novel therapeutic axis wherein targeting eIF5A2 hypusination disrupts TFEB-dependent autophagy to overcome lenvatinib resistance in HCC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang, China.
- Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
- Department of General Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui, 323000, Zhejiang, China.
- Cancer Institute of Integrated Traditional Chinese and Western Medicine, Key Laboratory of Cancer Prevention and Therapy Combining Traditional Chinese and Western Medicine of Zhejiang Province, Zhejiang Academy of Tradi…
- Department of General Surgery, Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, 323000, Zhejiang, China.
- Department of Thoracic Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, S., Zhou, Q., Lin, Q., Zhang, S., Cai, Y., Wu, F., Kuang, F., Wang, L., Xie, S., Lan, J., Zheng, L., Xu, G., Shao, C., Chen, W., & Tu, C. (2026). Targeting eIF5A2 hypusination with bikinin sensitizes hepatocellular carcinoma to lenvatinib by suppressing TFEB-mediated autophagy. Human Cell, 39(8). https://doi.org/10.1007/s13577-026-01426-9
Vancouver
Wang S, Zhou Q, Lin Q, Zhang S, Cai Y, Wu F, et al. Targeting eIF5A2 hypusination with bikinin sensitizes hepatocellular carcinoma to lenvatinib by suppressing TFEB-mediated autophagy. Human Cell. 2026;39(8). doi:10.1007/s13577-026-01426-9
BibTeX
@article{Wang2026,
author = {Wang, Shuqian and Zhou, Qingyun and Lin, Qiaomei and Zhang, Shufen and Cai, Ying and Wu, Fangnan and Kuang, Fangyuan and Wang, Lianghui and Xie, Shangzhi and Lan, Jiahua and Zheng, Li and Xu, Guodong and Shao, Chuxiao and Chen, Wei and Tu, Chaoyong},
title = {Targeting eIF5A2 hypusination with bikinin sensitizes hepatocellular carcinoma to lenvatinib by suppressing TFEB-mediated autophagy},
journal = {Human Cell},
year = {2026},
volume = {39},
number = {8},
doi = {10.1007/s13577-026-01426-9}
}
EUVIMED